Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models

Por um escritor misterioso

Descrição

Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
PIK3CA and APC mutations are synergistic in the development of
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Bcl9 and Pygo synergise downstream of Apc to effect intestinal
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Pygo and BCL9: the Wnt enhanceosome
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Functional redundancy between Apc and Apc2 regulates tissue
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Structural basis of the interaction between BCL9-Pygo and LDB-SSBP
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Structural basis of the interaction between BCL9-Pygo and LDB-SSBP
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
TBX3 acts as tissue-specific component of the Wnt/β-catenin
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to
de por adulto (o preço varia de acordo com o tamanho do grupo)